Viewing Study NCT05847088



Ignite Creation Date: 2024-05-06 @ 6:58 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05847088
Status: COMPLETED
Last Update Posted: 2023-05-06
First Post: 2023-04-05

Brief Title: Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema
Sponsor: Dar El Oyoun Hospital
Organization: Dar El Oyoun Hospital

Study Overview

Official Title: Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema Anatomical and Functional Outcomes of Treatment and Retreatment
Status: COMPLETED
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: We have been using DEX for refractory DME for a long time since 2016 Thus we are sharing our results evaluating both anatomical and functional outcomes of DEX therapy for refractory DME
Detailed Description: Our study aims at evaluating both anatomical and functional outcomes of DEX therapy for cases of refractory DME with both a single injection and or with retreatments

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None